IsoRay

We are committed to identifying ways to best deliver therapies for patients and their medical needs and believe in a targeted personalized approach to treating each patient’s cancer. We develop treatments that are delivered exactly where the surgeon wants them delivered. We believe radiation should spare healthy tissues and be delivered from the inside out. We use proprietary targeting peptides to diagnose tumors, and then deliver Alpha-Particle Radiopharmaceuticals to attack them on a molecular level when the cancer has spread to other sites in the body. The merger between Isoray and Viewpoint created a world-class organization with a vision of delivering personalized, targeted therapies from the inside out. Perspective Therapeutics is the only company in the world manufacturing and distributing Cesium 131 brachytherapy radioisotope seeds. Due to the unique characteristics of Cesium-131 we have been approached by leading cancer institutions to discuss combination therapies which we believe is one of the future value drivers for the company. The second trial, with another leading cancer institution, combines Cesium-131 with nivolumab to treat metastatic melanoma.